Press releases
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
More ▼
Key statistics
As of last trade Dexcom Inc (DC4:DUS) traded at 116.36, -11.38% below its 52-week high of 131.30, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 116.46 |
---|---|
High | 116.46 |
Low | 116.36 |
Bid | 116.24 |
Offer | 117.34 |
Previous close | 116.74 |
Average volume | 20.11 |
---|---|
Shares outstanding | 397.68m |
Free float | 396.22m |
P/E (TTM) | 83.96 |
Market cap | 50.66bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of May 29 2024 08:31 BST.
More ▼